{
    "title": "Biogen's Alzheimer's drug slows mental decline in early study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-3003860/Biogens-Alzheimers-drug-slows-mental-decline-early-study.html",
    "date": "2015-03-20",
    "keywords": [
        "plaque",
        "mg",
        "drug",
        "dose",
        "study",
        "treatment",
        "year",
        "trial",
        "group",
        "reduction",
        "decline",
        "disease",
        "brain",
        "sandrock",
        "placebo",
        "scale",
        "gmt",
        "march",
        "bill",
        "biogen",
        "time",
        "slowing",
        "dementia",
        "patient",
        "ariae",
        "mgkg",
        "email",
        "berkrotmarch",
        "idec",
        "care",
        "medicinebiogen",
        "field",
        "pfizer",
        "inc",
        "placebothe",
        "type",
        "role",
        "development",
        "meeting",
        "france",
        "impairment",
        "effect",
        "saidbiogen",
        "phase",
        "iii",
        "approval",
        "drugbiogen",
        "success",
        "diseasewe",
        "executive",
        "george",
        "interview",
        "reason",
        "activity",
        "drughigher",
        "effectsafety",
        "tolerability",
        "company",
        "jump",
        "incidence",
        "water",
        "tissue",
        "gene",
        "risk",
        "highestrisk",
        "rate",
        "amyloid",
        "kilogram",
        "weight",
        "aducanumab",
        "increase",
        "arm",
        "drugthe",
        "cognition",
        "questionnaire",
        "acuity",
        "rating",
        "loss",
        "ability",
        "test",
        "versus",
        "significance",
        "reporting",
        "berkrot",
        "gershberg",
        "leslie",
        "adler"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}